Skip to Main Content

Advertisement intended for health care professionals

Close

ASH Clinical News
ASH News Daily
ASH-SAP
Blood Journals
Hematology
The Hematologist
International
ASH
- ASH Home
- Research
- Education
- Advocacy
- Meetings
- Publications
- ASH Store

header search

search input Search input auto suggest

filter your search

Search

Menu

Issues
- Current Issue
- All Issues
First edition
Abstracts
Collections
Author Center
About

Skip Nav Destination

Issue Archive

Select Decade

Select Year

Issue

Volume 112, Issue 1

July 1 2008

In this Issue

INSIDE BLOOD
ASH 50TH ANNIVERSARY REVIEW
BLOOD WORK
PERSPECTIVE
CHEMOKINES, CYTOKINES, AND INTERLEUKINS
CLINICAL TRIALS AND OBSERVATIONS
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
IMMUNOBIOLOGY
NEOPLASIA
CORRESPONDENCE

Table of Contents

NEOPLASIA

MM-induced osteolysis: partners in crime

Carl Gregory

View Articletitled, MM-induced osteolysis: partners in crime

IMMUNOBIOLOGY

Inhibitions in NK-cell maturation

Werner Held

View Articletitled, Inhibitions in NK-cell maturation

INSIDE BLOOD

NEOPLASIA

Signals that maintain leukemic cell viability

Janet Plate

View Articletitled, Signals that maintain leukemic cell viability

NEOPLASIA

Ligandless receptors find a role

Terry J. Hamblin

View Articletitled, Ligandless receptors find a role

IMMUNOBIOLOGY

EnABLing the immune synapse

Naomi Rosenberg

View Articletitled, En<em>ABL</em>ing the immune synapse

HEMOSTASIS

Thrombus stability on the vessel wall

Alan T. Nurden

View Articletitled, Thrombus stability on the vessel wall

NEOPLASIA

Gang of 3 in aggressive CLL?

Grzegorz S. Nowakowski

View Articletitled, Gang of 3 in aggressive CLL?

HEMOSTASIS

Glucose, insulin, coagulation: endotoxin as exohormone

John C. Marshall

View Articletitled, Glucose, insulin, coagulation: endotoxin as exohormone

IMMUNOBIOLOGY

Thymocyte-fate decisions: bittersweet new flavor

Guy Werlen

View Articletitled, Thymocyte-fate decisions: bittersweet new flavor

HEMOSTASIS

Urokinase: the identity crisis continues

Steven L. Gonias

View Articletitled, Urokinase: the identity crisis continues

ASH 50TH ANNIVERSARY REVIEW

Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura

J. Evan Sadler

View Articletitled, Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura

Advances in understanding pathogenic mechanisms of thrombophilic disorders

Björn Dahlbäck

View Articletitled, Advances in understanding pathogenic mechanisms of thrombophilic disorders

BLOOD WORK

Skin lesions and mast cells

View Articletitled, Skin lesions and mast cells

PERSPECTIVE

Investment analysts and the American Society of Hematology

David P. Steensma

View Articletitled, Investment analysts and the American Society of Hematology

CHEMOKINES, CYTOKINES, AND INTERLEUKINS

CXCR4 dimerization and β-arrestin–mediated signaling account for the enhanced chemotaxis to CXCL12 in WHIM syndrome

Bernard Lagane,Ken Y. C. Chow,Karl Balabanian,Angélique Levoye,Julie Harriague,Thierry Planchenault,Françoise Baleux,Nathalie Gunera-Saad,Fernando Arenzana-Seisdedos,Françoise Bachelerie

View Articletitled, CXCR4 dimerization and β-arrestin–mediated signaling account for the enhanced chemotaxis to CXCL12 in WHIM syndrome

CLINICAL TRIALS AND OBSERVATIONS

Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs
Clinical Trials & Observations

Dana E. Rollison,Nadia Howlader,Martyn T. Smith,Sara S. Strom,William D. Merritt,Lynn A. Ries,Brenda K. Edwards,Alan F. List

View Articletitled, Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs

Characteristics and outcomes of patients with chronic myeloid leukemia and T315I mutation following failure of imatinib mesylate therapy
Brief Report

Elias Jabbour,Hagop Kantarjian,Dan Jones,Megan Breeden,Guillermo Garcia-Manero,Susan O'Brien,Farhad Ravandi,Gautam Borthakur,Jorge Cortes

View Articletitled, Characteristics and outcomes of patients with chronic myeloid leukemia and T315I mutation following failure of imatinib mesylate therapy

HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY

Guanine exchange factor RalGDS mediates exocytosis of Weibel-Palade bodies from endothelial cells

Mariska G. Rondaij,Ruben Bierings,Ellen L. van Agtmaal,Karina A. Gijzen,Erica Sellink,Astrid Kragt,Stephen S. G. Ferguson,Koen Mertens,Matthew J. Hannah,Jan A. van Mourik,Mar Fernandez-Borja,Jan Voorberg

View Articletitled, Guanine exchange factor RalGDS mediates exocytosis of Weibel-Palade bodies from endothelial cells

Supplemental data

Macrophage mannose receptor on lymphatics controls cell trafficking

Fumiko Marttila-Ichihara,Raisa Turja,Mari Miiluniemi,Marika Karikoski,Mikael Maksimow,Jussi Niemelä,Luisa Martinez-Pomares,Marko Salmi,Sirpa Jalkanen

View Articletitled, Macrophage mannose receptor on lymphatics controls cell trafficking

Supplemental data

Role of ephrinB2 expression in endothelial cells during arteriogenesis: impact on smooth muscle cell migration and monocyte recruitment

Thomas Korff,Jennifer Braun,Dennis Pfaff,Hellmut G. Augustin,Markus Hecker

View Articletitled, Role of ephrinB2 expression in endothelial cells during arteriogenesis: impact on smooth muscle cell migration and monocyte recruitment

Supplemental data

Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia

Michiel E. Stegenga,Saskia N. van der Crabben,Regje M. E. Blümer,Marcel Levi,Joost C. M. Meijers,Mireille J. Serlie,Michael W. T. Tanck,Hans P. Sauerwein,Tom van der Poll

View Articletitled, Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia

Identification of a fibrin-independent platelet contractile mechanism regulating primary hemostasis and thrombus growth

Akiko Ono,Erik Westein,Sarah Hsiao,Warwick S. Nesbitt,Justin R. Hamilton,Simone M. Schoenwaelder,Shaun P. Jackson

View Articletitled, Identification of a fibrin-independent platelet contractile mechanism regulating primary hemostasis and thrombus growth

Supplemental data

Nuclear translocation of urokinase-type plasminogen activator

Victoria Stepanova,Tatiana Lebedeva,Alice Kuo,Serge Yarovoi,Sergei Tkachuk,Sergei Zaitsev,Khalil Bdeir,Inna Dumler,Michael S. Marks,Yelena Parfyonova,Vsevolod A. Tkachuk,Abd Al-Roof Higazi,Douglas B. Cines

View Articletitled, Nuclear translocation of urokinase-type plasminogen activator

Supplemental data

IMMUNOBIOLOGY

The c-Abl tyrosine kinase regulates actin remodeling at the immune synapse

Yanping Huang,Erin O. Comiskey,Renell S. Dupree,Shuixing Li,Anthony J. Koleske,Janis K. Burkhardt

View Articletitled, The c-Abl tyrosine kinase regulates actin remodeling at the immune synapse

Supplemental data

Endogenous galectin-1 enforces class I–restricted TCR functional fate decisions in thymocytes

Scot D. Liu,Chan C. Whiting,Tamar Tomassian,Mabel Pang,Stephanie J. Bissel,Linda G. Baum,Valeri V. Mossine,Françoise Poirier,Margaret E. Huflejt,M. Carrie Miceli

View Articletitled, Endogenous galectin-1 enforces class I–restricted TCR functional fate decisions in thymocytes

Enhanced NK-cell development and function in BCAP-deficient mice

Alexander W. MacFarlane, IV,Tetsuo Yamazaki,Min Fang,Luis J. Sigal,Tomohiro Kurosaki,Kerry S. Campbell

View Articletitled, Enhanced NK-cell development and function in BCAP-deficient mice

Supplemental data

NEOPLASIA

MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort

Philip A. Beer,Peter J. Campbell,Linda M. Scott,Anthony J. Bench,Wendy N. Erber,David Bareford,Bridget S. Wilkins,John T. Reilly,Hans C. Hasselbalch,Richard Bowman,Keith Wheatley,Georgina Buck,Claire N. Harrison,Anthony R. Green

View Articletitled, <em>MPL</em> mutations in myeloproliferative disorders: analysis of the PT-1 cohort

Supplemental data

SDF-1/CXCR4 and VLA-4 interaction regulates homing in Waldenstrom macroglobulinemia

Hai T. Ngo,Xavier Leleu,Jack Lee,Xiaoying Jia,Molly Melhem,Judith Runnels,Anne-Sophie Moreau,Nicholas Burwick,Abdel Kareem Azab,Aldo Roccaro,Feda Azab,Antonio Sacco,Mena Farag,Robert Sackstein,Irene M. Ghobrial

View Articletitled, SDF-1/CXCR4 and VLA-4 interaction regulates homing in Waldenstrom macroglobulinemia

Role of decorin in the antimyeloma effects of osteoblasts

Xin Li,Angela Pennisi,Shmuel Yaccoby

View Articletitled, Role of decorin in the antimyeloma effects of osteoblasts

α4β1 integrin and 190-kDa CD44v constitute a cell surface docking complex for gelatinase B/MMP-9 in chronic leukemic but not in normal B cells

Javier Redondo-Muñoz,Estefanía Ugarte-Berzal,José A. García-Marco,Mercedes Hernández del Cerro,Philippe E. Van den Steen,Ghislain Opdenakker,María José Terol,Angeles García-Pardo

View Articletitled, α4β1 integrin and 190-kDa CD44v constitute a cell surface docking complex for gelatinase B/MMP-9 in chronic leukemic but not in normal B cells

Supplemental data

FCRL2 expression predicts IGHV mutation status and clinical progression in chronic lymphocytic leukemia

Fu Jun Li,Shouluan Ding,Jicun Pan,Mikhail A. Shakhmatov,Elena Kashentseva,Jiongru Wu,Yufeng Li,Seng-jaw Soong,Nicholas Chiorazzi,Randall S. Davis

View Articletitled, FCRL2 expression predicts <em>IGHV</em> mutation status and clinical progression in chronic lymphocytic leukemia

Supplemental data

Constitutive activation of distinct BCR-signaling pathways in a subset of CLL patients: a molecular signature of anergy

Marta Muzio,Benedetta Apollonio,Cristina Scielzo,Michela Frenquelli,Irene Vandoni,Vassiliki Boussiotis,Federico Caligaris-Cappio,Paolo Ghia

View Articletitled, Constitutive activation of distinct BCR-signaling pathways in a subset of CLL patients: a molecular signature of anergy

Myeloma-derived Dickkopf-1 disrupts Wnt-regulated osteoprotegerin and RANKL production by osteoblasts: a potential mechanism underlying osteolytic bone lesions in multiple myeloma

Ya-Wei Qiang,Yu Chen,Owen Stephens,Nathan Brown,Bangzheng Chen,Joshua Epstein,Bart Barlogie,John D. Shaughnessy, Jr

View Articletitled, Myeloma-derived Dickkopf-1 disrupts Wnt-regulated osteoprotegerin and RANKL production by osteoblasts: a potential mechanism underlying osteolytic bone lesions in multiple myeloma

CORRESPONDENCE

About multiple sclerosis, natalizumab, and CD34⁺ hematopoietic progenitors

Carine Vuaillat,Géraldine Androdias,Nathalie Davoust,Serge Nataf

View Articletitled, About multiple sclerosis, natalizumab, and CD34<sup>+</sup> hematopoietic progenitors

Response: More about multiple sclerosis, natalizumab, and CD34⁺ hematopoietic progenitors

Halvard Bonig,Annette Wundes,Thalia Papayannopoulou

View Articletitled, Response: More about multiple sclerosis, natalizumab, and CD34<sup>+</sup> hematopoietic progenitors

Response: Natalizumab-induced mobilization of CD34⁺ hematopoietic progenitor cells

Fabian Zohren

View Articletitled, Response: Natalizumab-induced mobilization of CD34<sup>+</sup> hematopoietic progenitor cells

Cover Image

Cover Image

Confocal image of a human umbilical vein endothelial cell treated by small inhibitory RNA knock-down of the guanine exchange factor RalGDS and then epinephrine. Weibel-Palade bodies were visualized by immunofluorescent staining of von Willebrand factor (green) while staining of beta-catenin (red) was used to delineate the cell membrane. See related article by Rondaij et al on page 56.
Front Matter
Table of Contents
Back Matter
Advertising
Editorial Board

Advertisement intended for health care professionals

Email alerts

First Edition Alert

Latest Issue Alert

Latest
Most Read
Most Cited

Targeting DOT1L and EZH2 synergizes in breaking the germinal center identity of Diffuse Large B-cell Lymphoma

High-throughput drug screening identifies SMAC mimetics as enhancers of NK cell cytotoxicity in chronic myeloid leukemia

Donor Regulatory T-Cell Therapy to Prevent Graft-Versus-Host Disease

Epcoritamab plus GemOx in transplant-ineligible relapsed/refractory DLBCL: results from the EPCORE NHL-2 trial

Doubling down on GPRC5D in multiple myeloma

Advertisement intended for health care professionals

Advertisement intended for health care professionals

Current Issue
First edition
All Issues

Collections
Abstracts
Authors

Submit to Blood
About Blood
Subscriptions

Public Access
Permissions
Alerts

Contact Us
Newsroom
Blood Classifieds

Advertising in Blood
Terms and Conditions
Twitter

American Society of Hematology
2021 L Street NW, Suite 900
Washington, DC 20036
TEL +1 202-776-0544
FAX +1 202-776-0545

ASH Publications

Blood
Blood Advances
Blood Global Hematology
Blood Immunology & Cellular Therapy
Blood Neoplasia
Blood Red Cells & Iron
Blood Vessels, Thrombosis & Hemostasis
Hematology, ASH Education Program
ASH Clinical News
ASH-SAP
The Hematologist

American Society of Hematology

ASH Home
Research
Education
Advocacy
Meetings
Publications
ASH Store

Copyright 2024 by American Society of Hematology

Cookie Settings
Privacy Policy
Cookie Policy
Terms of Use
Contact Us

This Feature Is Available To Subscribers Only

Sign In or Create an Account

Advertisement intended for health care professionals